Trailing-twelve-month (TTM) revenue is $19.68 Billion with a year-over-year growth of +14.64%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $4,331,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $4,121,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-18 |
| Q1 FY2026Period ended 2026-03-31 | $3,807,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $7,417,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $19,676,000,000 |
Current P/S: $52,035,500,000 market capitalization ÷ $19,676,000,000 TTM revenue = 2.64x.
Market capitalization source: FMP quote. Quote observed 2026-09-28T15:30:31.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $7.42B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-28T15:32:11.419Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2018-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20162016-12-31 · USD | FY20172017-12-31 · USD | FY20182018-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Canada Business Segment | $1.0B | $1.6B | $814M | N/A | N/A | N/A |
| General Partner And En Link | $3.6B | $5.1B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20132013-12-31 · USD | FY20142014-12-31 · USD | FY20152015-12-31 · USD | FY20162016-12-31 · USD | FY20172017-12-31 · USD | FY20182018-12-31 · USD |
|---|---|---|---|---|---|---|
| C [A] | $92M | $2.1B | $1.0B | $984M | $1.4B | $814M |
| U [S] | $2.0B | $14.9B | $4.4B | $3.2B |
$19.68B
$19.68 Billion
+14.64%
vs. $17.16B a year ago (TTM)
+23.63%
5 Year compound annual growth rate
1 Year
+14.64%
3 Year
+4.98%
5 Year
+23.63%
10 Year
+5.89%
15 Year
+5.68%
20 Year
+3.06%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $17.19B | +$1.25B | +7.83% |
| 2024 | $15.94B | +$682.00M | +4.47% |
| 2023 | $15.26B | ($3.91B) | (20.40%) |
| 2022 | $19.17B | +$6.96B | +57.05% |
| 2021 | $12.21B | +$7.38B | +152.82% |
| 2020 |
TTM Growth
+14.64%
3-Year CAGR
+4.98%
5-Year CAGR
+23.63%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-28T15:32:11.419Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
| N/A |
| N/A |
| N/A |
| N G L Product Sales | N/A | N/A | N/A | $10.8B | $11.2B | $11.2B |
|---|
| United States Business Segment | $5.7B | $7.3B | $4.9B | N/A | N/A | N/A |
|---|
| $4.9B |
| $4.83B |
| ($1.39B) |
| (22.38%) |
| 2019 | $6.22B | ($2.68B) | (30.08%) |
| 2018 | $8.90B | +$2.40B | +36.84% |
| 2017 | $6.50B | ($3.80B) | (36.91%) |
| 2016 | $10.30B | ($2.84B) | (21.61%) |
